{"disease":{"id":"uterine-tumor","name":"uterine tumor"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07480785","title":"TEAS Combined With Triple Antiemetic Drugs to Prevent PONV in High-Risk Patients","phase":"NA","overall_status":"RECRUITING","enrollment_count":780,"lead_sponsor_name":"Zhejiang University","has_results":false},{"nct_id":"NCT01365169","title":"Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients\"","phase":"NA","overall_status":"RECRUITING","enrollment_count":590,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT05256225","title":"Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":360,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT01010126","title":"Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":252,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT06963385","title":"Radiomics and Molecular Classification in Endometrial Cancer","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":250,"lead_sponsor_name":"Fondazione IRCCS Istituto Nazionale dei Tumori, Milano","has_results":false},{"nct_id":"NCT04272216","title":"An Observational Study of Radial Access Embolization Procedures Using HydroPearl Microspheres","phase":"","overall_status":"COMPLETED","enrollment_count":99,"lead_sponsor_name":"Terumo Medical Corporation","has_results":true},{"nct_id":"NCT07264660","title":"Diagnostic Value of Transcervical True-Cut Biopsy in Uterine Masses","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":42,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT07118176","title":"Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Jonsson Comprehensive Cancer Center","has_results":false}],"total":8},"guidelines":[],"source":"Drug Landscape verified database"}